CXCL13 is highly upregulated in active MS lesions and in the cerebrospinal fluid (CSF) of relapsing-remitting MS (RRMS) patients, with peaks of expression during relapses [13,14]. This evidence concerns the gene CXCL13 and relapsing-remitting multiple sclerosis.